Johnson and Johnson gets CDSCO panel nod to study Paliperidone Palmitate Roshni Dhar1 Oct 2022 12:23 PM GMTPharmaceutical major, Johnson and Johnson has got a go ahead from the Subject Expert Committee SEC functional under Central Drug Standard Control...
Health Bulletin 30/September/2022 Roshni Dhar30 Sep 2022 12:04 PM GMTHere are the top health news for the day:Delhi: Safdarjung Hospital to ban 3-wheelerIn an order to curb pollution, Safdarjung Hospital is going to ban...
JnJ gets CDSCO Panel nod to study antipsychotic drug Paliperidone Palmitate Dr. Divya Colin29 Sep 2022 12:30 PM GMTNew Delhi: Pharmaceutical major, Johnson and Johnson has got a go ahead from the Subject Expert Committee SEC functional under Central Drug Standard...
Paliperidone palmitate initiation tied to higher treatment continuation in schizophrenia: BMC Dr. Hiral patel22 Jun 2022 4:00 AM GMTEurope: In schizophrenia patients, paliperidone palmitate is associated with a significantly higher treatment continuation than risperidone...
There is no unmet need: CDSCO Panel rejects J&J proposal to Import and manufacture Paliperidone Palmitate Dr. Divya Colin29 May 2022 5:59 AM GMTNew Delhi: Citing that there is no unmet need, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
